SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 299 filers reported holding SEATTLE GENETICS INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $140,098,000 | +2120.6% | 2,574,895 | +2465.0% | 1.20% | +2349.0% |
| Q1 2017 | $6,309,000 | -15.0% | 100,385 | -28.6% | 0.05% | 0.0% |
| Q4 2016 | $7,421,000 | -46.6% | 140,670 | -45.4% | 0.05% | -42.4% |
| Q3 2016 | $13,910,000 | +50.8% | 257,580 | +12.8% | 0.08% | +51.8% |
| Q2 2016 | $9,224,000 | -9.1% | 228,321 | -21.0% | 0.06% | -5.1% |
| Q1 2016 | $10,144,000 | -36.8% | 289,140 | -19.2% | 0.06% | -37.2% |
| Q4 2015 | $16,054,000 | -26.9% | 357,750 | -29.1% | 0.09% | +77.4% |
| Q3 2015 | $21,952,000 | +79.7% | 504,940 | +100.0% | 0.05% | 0.0% |
| Q2 2015 | $12,218,000 | -29.8% | 252,470 | -48.8% | 0.05% | -35.4% |
| Q1 2015 | $17,415,000 | +11.6% | 492,690 | +1.4% | 0.08% | +18.8% |
| Q4 2014 | $15,608,000 | -13.6% | 485,810 | 0.0% | 0.07% | -8.0% |
| Q3 2014 | $18,061,000 | +18.2% | 485,810 | +21.6% | 0.08% | +27.1% |
| Q2 2014 | $15,279,000 | +22.9% | 399,490 | +46.3% | 0.06% | +15.7% |
| Q1 2014 | $12,436,000 | -15.6% | 272,980 | -26.1% | 0.05% | -23.9% |
| Q4 2013 | $14,727,000 | -11.8% | 369,210 | -3.1% | 0.07% | -15.2% |
| Q3 2013 | $16,704,000 | -0.3% | 381,140 | -28.4% | 0.08% | -11.2% |
| Q2 2013 | $16,746,000 | – | 532,360 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |